Innova Wealth Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Buy
5,291
+1,008
+24% +$68.7K 0.17% 103
2026
Q1
$277K Buy
4,283
+665
+18% +$46.9K 0.13% 127
2025
Q4
$243K Buy
+3,618
New +$243K 0.12% 125

Other funds holding HALO

Innova Wealth Partners's HALO Position: Q2 2026 in Review

Innova Wealth Partners increased its Halozyme (HALO) stake by 24% in Q2 2026, buying an estimated $68.7K and bringing the position to 5,291 shares worth $414K. The position accounts for 0.17% of the portfolio, ranked #103.

Innova Wealth Partners first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 222 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Innova Wealth Partners held 5,291 shares of Halozyme worth $414K as of Q2 2026.
  • Innova Wealth Partners bought 1,008 Halozyme shares in Q2 2026, an estimated $68.7K.
  • Halozyme made up 0.17% of Innova Wealth Partners's portfolio in Q2 2026, its #103 holding.
  • Innova Wealth Partners first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • 222 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Innova Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.